Zhou P-H, Zheng J-B, Wei G-B, Wang X-L, Wang W, Chen N-Z, Yu J-H, Yao J-F, Wang H, Lu S-Y, Sun X-J
Department of General Surgery, The First Affiliated Hospital, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Gene Ther. 2015 Oct;22(10):793-801. doi: 10.1038/gt.2015.49. Epub 2015 May 25.
Loss of Ras association domain family protein 1 isoform A (RASSF1A) expression is associated with the development of a variety of human cancers and the expression of carcinoembryonic antigen (CEA) frequently occurs in gastric cancer. This study investigated the effects of RASSF1A expression restoration using a hypoxia-inducible CEA promoter-driven vector on xenograft tumor growth in nude mice and on the in-vitro regulation of gastric cancer cell viability, cell cycle distribution, apoptosis, colony formation and invasion capacity. The data showed that the level of CEA mRNA and protein was much higher in gastric cancer SGC7901 cells than in a second gastric cancer cell line, MKN28, or in the MCF-10A normal epithelial breast cell line. RASSF1A expression was restored in SGC7901 cells compared with the negative control virus-infected SGC7910 cells. RASSF1A expression restoration significantly inhibited gastric cancer cell viability, colony formation and invasion capacity, but induced cell cycle arrest and apoptosis in vitro, especially under hypoxic culture conditions. At the gene level, restoration of RASSF1A expression under hypoxic culture conditions significantly suppressed matrix metalloproteinase-2 expression and prevented cyclinD1 expression. A nude mouse xenograft assay showed that the restoration of RASSF1A expression reduced gastric cancer xenograft formation and growth. In conclusion, the restoration of RASSF1A expression using a hypoxia-inducible and CEA promoter-driven vector suppressed aggressive phenotypes of gastric cancer cells in vitro and in vivo. These results suggest that LV-5HRE-CEAp-RASSF1A gene therapy may be a promising novel approach to treat advanced gastric cancer.
Ras关联结构域家族蛋白1亚型A(RASSF1A)表达缺失与多种人类癌症的发生发展相关,癌胚抗原(CEA)的表达在胃癌中也经常出现。本研究利用缺氧诱导的CEA启动子驱动载体恢复RASSF1A表达,探讨其对裸鼠移植瘤生长以及对胃癌细胞活力、细胞周期分布、凋亡、集落形成和侵袭能力的体外调控作用。数据显示,胃癌SGC7901细胞中CEA mRNA和蛋白水平明显高于另一种胃癌细胞系MKN28或MCF-10A正常乳腺上皮细胞系。与阴性对照病毒感染的SGC7910细胞相比,SGC7901细胞中RASSF1A表达得以恢复。RASSF1A表达恢复显著抑制胃癌细胞活力、集落形成和侵袭能力,但在体外诱导细胞周期停滞和凋亡,尤其是在低氧培养条件下。在基因水平,低氧培养条件下RASSF1A表达恢复显著抑制基质金属蛋白酶-2表达并阻止细胞周期蛋白D1表达。裸鼠移植瘤实验表明,RASSF1A表达恢复减少了胃癌移植瘤的形成和生长。总之,利用缺氧诱导且CEA启动子驱动的载体恢复RASSF1A表达在体外和体内均抑制了胃癌细胞的侵袭性表型。这些结果表明,LV-5HRE-CEAp-RASSF1A基因治疗可能是一种有前景的治疗晚期胃癌的新方法。